Raia Drogasil S/A Current Liabilities
The Current Liabilities of Raia Drogasil S/A (RADL3.SA) as of Nov 5, 2026 is 10.19 B BRL. In the previous year, Current Liabilities was 12.01 B BRL — a change of -15.10% (lower).
Get this data via API
Financial Data API
Current Liabilities
10.19 BBRL
YoY
-15.10%
Last updated:
The Raia Drogasil S/A Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 10.19 BBRL | -15.10% | |
| 12.01 BBRL | +18.15% | |
| 10.16 BBRL | +24.24% | |
| 8.18 BBRL | +2.96% | |
| 7.94 BBRL | +27.98% | |
| 6.21 BBRL | +18.85% | |
| 5.22 BBRL | +49.27% | |
| 3.50 BBRL | +18.40% | |
| 2.96 BBRL | +14.86% | |
| 2.57 BBRL | +30.82% | |
| 1.97 BBRL | +27.19% | |
| 1.55 BBRL | +24.66% | |
| 1.24 BBRL | +20.80% | |
| 1.03 BBRL | +8.55% | |
| 945.90 MBRL | +193.66% | |
| 322.11 MBRL | -2.21% | |
| 329.38 MBRL | +47.65% | |
| 223.08 MBRL | +5.42% | |
| 211.62 MBRL | +11.37% | |
| 190.02 MBRL | +32.74% | |
| 143.15 MBRL | +36.41% | |
| 104.94 MBRL | +26.88% | |
| 82.71 MBRL | +31.17% | |
| 63.06 MBRL | +23.40% | |
| 51.10 MBRL | +3.89% | |
| 49.19 MBRL | +24.20% | |
| 39.60 MBRL | +30.69% | |
| 30.30 MBRL | +13.06% | |
| 26.80 MBRL | +5.51% | |
| 25.40 MBRL | +46.82% | |
| 17.30 MBRL | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Raia Drogasil S/A Stock analysis
Frequently Asked Questions about Raia Drogasil S/A stock
Current Liabilities of Raia Drogasil S/A is 10.19 B BRL in 2025.
Current Liabilities of Raia Drogasil S/A changed from 12.01 B BRL to 10.19 B BRL, representing a -15.10% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Raia Drogasil S/A since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Raia Drogasil S/A historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Raia Drogasil S/A
All Key Metrics — Raia Drogasil S/A
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth